About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
DPA International on MSN17m
Novartis to buy Anthos Therapeutics in $3.1 bn dealSwiss pharmaceutical firm Novartis said on Tuesday that it has agreed to buy privately held, clinical-stage US biotech Anthos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback